AOBXFVUTKIJARA-WFUSLXQSSA-N
Compound with spectra: 1 NMR
| SpectraBase Compound ID | B04IJNeSixc |
|---|---|
| InChI | InChI=1S/C87H163O10PS2Si5/c1-35-46-74(83(88)87(27,98(89,72-47-41-39-42-48-72)73-49-43-40-44-50-73)60-67(17)55-79(91-29)82(96-102(33,34)86(24,25)26)80(92-30)57-69(19)84-99-53-45-54-100-84)77(93-101(31,32)85(21,22)23)59-76(95-105(64(11)12,65(13)14)66(15)16)70(20)81(97-103(36-2,37-3)38-4)68(18)56-71-51-52-75(78(58-71)90-28)94-104(61(5)6,62(7)8)63(9)10/h35,39-44,47-50,56,61-67,69-71,74-84,88H,1,36-38,45-46,51-55,57-60H2,2-34H3/b68-56+/t67-,69-,70+,71-,74?,75+,76+,77-,78+,79+,80+,81+,82-,83?,87?/m1/s1 |
| InChIKey | AOBXFVUTKIJARA-WFUSLXQSSA-N |
| Mol Weight | 1604.8 g/mol |
| Molecular Formula | C87H163O10PS2Si5 |
| Exact Mass | 1603.027163 g/mol |
| Enantiomer InChIKey | AOBXFVUTKIJARA-NLMHMRIMSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
N-[7-(2,3,5-TRI-O-ACETYL-BETA-D-RIBOFURANOSYL)-1H,7H-IMIDAZO-[4,5-B]-PYRAZOLO-[3,4-E]-PYRIDIN-1-YL]-ACETAMIDE
5H-Pyrido[4,3-b]indole-1,3,4-tricarboxylic acid, 1-ethyl 3,4-dimethyl ester
6-HYDROXYPUNCTAPORONIN_A
ROUYOLIDE-D
ROUYOLIDE-E
5.ALPHA.-ANDROSTANE-9,17.BETA.-DIOL-3-ONE-TRIMETHYLSILYL ETHER
3a-(3,5-Dinitro-benzoyloxy)-8-methyl-decahydro-cyclopenta[a]indene-8a-carboxylic acid
(-)-3-Desoxoaristotelone
Hetacillin methyl-ester
2,10-DI-TERT.-BUTYL-4,8-BIS-[(2S,4S)-4-BENZYL-3-(4-METHYLBENZENESULFONYL)-1,3-OXAZOLIDINYL]-2-PHENOXY-DIBENZO-[D,F]-[1,3,2]-DIOXAPHOSPHEPINE
| Title | Journal or Book | Year |
|---|---|---|
| Chemistry of tricarbonyl hemiketals and application of Evans technology to the total synthesis of the immunosuppressant (-)-FK-506 | Journal of the American Chemical Society | 1990 |
KnowItAll NMR Spectral Library
Author: Wiley
The KnowItAll NMR Spectral Library offers a comprehensive collection of NMR reference spectra, including NMR, CNMR, and XNMR, and covers a wide range of compounds including organics, polymers, monomers, metabolites, and more. Learn more.